Ekso Bionics (EKSO) Stock
Medical and industrial powered exoskeleton designer. Here's the price, business snapshot, and what's worth knowing about Ekso Bionics in September 2026.
Ekso Bionics Holdings, Inc. (EKSO) designs and sells powered exoskeletons for medical rehabilitation and industrial applications. Its products — including wearable robotic suits for gait and upper‑limb support and industrial assistive devices — aim to help patients regain mobility and reduce workplace strain. For investors, Ekso is a small, speculative company: with a market capitalisation around $12.8m it may face limited liquidity, wide price swings and heightened sensitivity to funding and order flow. Key drivers include clinical adoption, favourable reimbursement and industrial safety demand; headwinds include competition, regulatory hurdles, manufacturing scale‑up and possible cash‑burn. Public information on revenues, profit and cash runway should be checked before considering exposure. This summary is educational only, not personalised advice. Values can rise or fall and past performance is not a guide to future returns. Ekso may suit investors seeking exposure to assistive robotics with a high risk tolerance and time horizon; those unsure should consult a qualified financial adviser.
About This Stock
EKSO BIONICS HOLDINGS INC
EKSO
Current Price
$0.00
Potential 12 Month Profit
-26.01%
Sector
Healthcare
Industry
Healthcare Equipment & Supplies
Ticker
EKSO
Market Cap
$42.01M
Potential 12 Month Profit
-26.01%
Sector
Healthcare
Industry
Healthcare Equipment & Supplies
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Ekso Bionics' stock with a target price of $10, indicating significant growth potential.
Financial Health
Ekso Bionics has steady revenue and cash flow, but its profitability remains a moderate concern.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Assistive Robotics Growth
Ageing populations and rehabilitation needs may support long‑term demand, though commercial adoption can be slow and outcomes uncertain.
Industrial Support Tools
Exoskeletons for workplaces aim to reduce injury and improve productivity; pilot programmes drive interest but scale and cost remain hurdles.
Small‑Cap Considerations
With a modest market cap, EKSO can be volatile and less liquid — investors should weigh reward potential against higher risk and possible dilution.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.